[HTML][HTML] Natural killer cells: a promising immunotherapy for cancer

J Chu, F Gao, M Yan, S Zhao, Z Yan, B Shi… - Journal of translational …, 2022 - Springer
As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …

[HTML][HTML] Toll-like receptor 4 (TLR4): new insight immune and aging

HJ Kim, H Kim, JH Lee, C Hwangbo - Immunity & Ageing, 2023 - Springer
TLR4, a transmembrane receptor, plays a central role in the innate immune response. TLR4
not only engages with exogenous ligands at the cellular membrane's surface but also …

[HTML][HTML] Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

H Sun, Y Li, P Zhang, H Xing, S Zhao, Y Song… - Biomarker …, 2022 - Springer
Toll-like receptors (TLRs) are a large family of proteins that are expressed in immune cells
and various tumor cells. TLR7/8 are located in the intracellular endosomes, participate in …

[HTML][HTML] Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset

I Veneziani, C Alicata, A Pelosi… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Toll-like receptors (TLRs) are pattern-recognition sensors mainly expressed in
innate immune cells that directly recognize conserved pathogen structures (pathogen …

[HTML][HTML] Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor

X Li, L Chen, X Peng, X Zhan - Frontiers in Oncology, 2022 - frontiersin.org
As a significant public health problem with high morbidity and mortality worldwide, tumor is
one of the major diseases endangering human life. Moreover, metastasis is the most …

[HTML][HTML] Human toll-like receptor 8 (TLR8) in NK cells: implication for cancer immunotherapy

I Veneziani, C Alicata, L Moretta, E Maggi - Immunology Letters, 2023 - Elsevier
Toll-like receptors (TLR) s are homo-or heterodimeric proteins, whose structure and function
were widely described in the antigen presenting cells (APC), such as Dendritic cells (DC) …

[HTML][HTML] Toll-like receptors: New targets for multiple myeloma treatment?

O Akesolo, B Buey, M Beltrán-Visiedo… - Biochemical …, 2022 - Elsevier
Despite recent biomedical improvements in treating multiple myeloma, this disease still
remains incurable. Toll-like receptors (TLRs) are key immune receptors that recognize …

Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure

L Wang, G Zhang, Y Sun, Z Wu, C Ren… - … Applied Materials & …, 2022 - ACS Publications
Hepatitis B virus (HBV) infection remains a major challenge to global health due to
unsatisfactory treatment efficacy, side effects of current therapies, and immune tolerance …

Toll-like receptors 7/8: a paradigm for the manipulation of immunologic reactions for immunotherapy

F Li, B Song, WF Zhou, LJ Chu - Viral Immunology, 2023 - liebertpub.com
The innate immune system recognizes conserved features of viral and microbial pathogens
through pattern recognition receptors (PRRs). Toll-like receptors (TLR s) are one type of …

Tumor-associated macrophages: reasons to be cheerful, reasons to be fearful

I Szulc-Kielbik, M Kielbik - Interaction of Immune and Cancer Cells, 2022 - Springer
Tumor microenvironment (TME) is a complex and constantly evolving entity that consists not
only of cancer cells, but also of resident host cells and immune-infiltrating cells, among …